Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Penile cancer, Secondary cancers
Closed
Phase 2
This trial is looking at adding cemiplimab to chemotherapy. It is also looking at how well cemiplimab works on its own.
It is for people with penile cancer that has spread to:
nearby areas of the body (locally advanced) or
a distant site in the body (metastatic)
Recruitment start: 23 May 2021
Recruitment end: 12 July 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Amit Bahl
Sanofi-Genzyme
University Hospitals Bristol and Weston NHS Foundation Trust
Last reviewed: 11 July 2024
CRUK internal database number: 17501